D. Western Therapeutics Institute, Inc. (TYO:4576)
Japan flag Japan · Delayed Price · Currency is JPY
47.00
-1.00 (-2.08%)
Nov 18, 2026, 11:30 AM JST

TYO:4576 Income Statement

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
140.9387471428448414
Revenue Growth
-66.43%-17.83%10.05%-4.46%8.21%16.62%
Cost of Revenue
8.943947362821
Gross Profit
131.97348424392420393
Selling, General & Admin
273.94298265258255248
Research & Development
482.586691,367930469316
Operating Expenses
758.49681,6341,190726565
Operating Income
-626.43-620-1,210-798-306-172
Interest Expense
-12.92-8-5-2-3-4
Interest & Investment Income
3.442----
Currency Exchange Gain (Loss)
4.247163317
Other Non Operating Income (Expenses)
-8.81-12-13-2-20-
EBT Excluding Unusual Items
-640.48-631-1,227-796-296-159
Gain (Loss) on Sale of Investments
----12-100-
Gain (Loss) on Sale of Assets
---2---
Asset Writedown
----6--
Legal Settlements
-----44-
Other Unusual Items
---60-12--
Pretax Income
-640.48-631-1,289-826-440-159
Income Tax Expense
0.811111
Earnings From Continuing Operations
-641.28-632-1,290-827-441-160
Minority Interest in Earnings
---151212
Net Income
-641.28-632-1,290-812-429-148
Net Income to Common
-641.28-632-1,290-812-429-148
Net Income Growth
------
Shares Outstanding (Basic)
564835323029
Shares Outstanding (Diluted)
564835323029
Shares Change
26.02%36.48%10.51%7.22%1.04%7.96%
EPS (Basic)
-11.49-13.19-36.73-25.55-14.47-5.05
EPS (Diluted)
-11.49-13.19-36.73-25.55-14.47-5.05
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
--495-1,308-598-363-178
Free Cash Flow Per Share
--10.33-37.24-18.82-12.25-6.07
Gross Margin
93.66%89.92%90.02%91.59%93.75%94.93%
Operating Margin
-444.59%-160.21%-256.90%-186.45%-68.30%-41.55%
Profit Margin
-455.12%-163.31%-273.88%-189.72%-95.76%-35.75%
Free Cash Flow Margin
--127.91%-277.71%-139.72%-81.03%-42.99%
EBITDA
-580.93-573-1,161-750-260-127
EBITDA Margin
--148.06%-246.50%-175.23%-58.04%-30.68%
D&A For EBITDA
45.54749484645
EBIT
-626.43-620-1,210-798-306-172
EBIT Margin
--160.21%-256.90%-186.45%-68.30%-41.55%